scholarly journals Neuropsychiatric symptoms are associated with increased risks of progression to dementia: a 2-year prospective study of 321 Chinese older persons with mild cognitive impairment

2010 ◽  
Vol 40 (1) ◽  
pp. 30-35 ◽  
Author(s):  
W. C. Chan ◽  
L. C. W. Lam ◽  
C. W. C. Tam ◽  
V. W. C. Lui ◽  
G. T. Y. Leung ◽  
...  
2010 ◽  
Vol 18 (10) ◽  
pp. 948-954 ◽  
Author(s):  
Wai-Chi Chan ◽  
Linda Chiu-Wa Lam ◽  
Cindy Woon-Chi Tam ◽  
Victor Wing-Cheong Lui ◽  
Sandra Sau-Man Chan ◽  
...  

2017 ◽  
pp. 1-6
Author(s):  
K. Sejunaite ◽  
C. Lanza ◽  
S. Ganders ◽  
A. Iljaitsch ◽  
M.W. Riepe

Background: Impairment of autonomous way-finding subsequent to a multitude of neurodegenerative and other diseases impedes independence of older persons and their everyday activities. Objective: It was the goal to use augmented reality to aid autonomous way-finding in a community setting. Design: A spatial map and directional information were shown via head-up display to guide patients from the start zone on the hospital campus to a bakery in the nearby community. Setting: Hospital campus and nearby community. Participants: Patients with mild cognitive impairment (age 63 to 89). Interventions: A head-up display was used to help patients find their way. Measurements: Time needed to reach goal and number of assists needed. Results: With use of augmented reality device, patients preceded along the correct path in 113 out of 120 intersections. Intermittent reassurance was needed for most patients. Patients affirmed willingness to use such an augmented reality device in everyday life if needed or even pay for it. Conclusion: Augmented reality guided navigation is a promising means to sustain autonomous way-finding as a prerequisite for autonomy of older persons in everyday activities. Thus, this study lays ground for a field trial in the community using assistive technology for older persons with cognitive impairment.


2018 ◽  
Vol 94 (1117) ◽  
pp. 647-652 ◽  
Author(s):  
Georges Assaf ◽  
Maria Tanielian

Dementia is projected to become a global health priority but often not diagnosed in its earlier preclinical stage which is mild cognitive impairment (MCI). MCI is generally referred as a transition state between normal cognition and Alzheimer’s disease. Primary care physicians play an important role in its early diagnosis and identification of patients most likely to progress to Alzheimer’s disease while offering evidenced-based interventions that may reverse or halt the progression to further cognitive impairment. The aim of this review is to introduce the concept of MCI in primary care through a case-based clinical review. We discuss the case of a patient with MCI and provide an evidence-based framework for assessment, early recognition and management of MCI while addressing associated risk factors, neuropsychiatric symptoms and prognosis.


2018 ◽  
Vol 81 (10) ◽  
pp. 555-565 ◽  
Author(s):  
Ann-Helen Patomella ◽  
Meryl Lovarini ◽  
Eva Lindqvist ◽  
Anders Kottorp ◽  
Louise Nygård

Sign in / Sign up

Export Citation Format

Share Document